Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development
- PMID: 25994916
- DOI: 10.1007/s13365-015-0350-2
Reverse genetics of rabies virus: new strategies to attenuate virus virulence for vaccine development
Abstract
Rabies is an ancient neurological disease that is almost invariably fatal once the clinical symptoms develop. Currently, prompt wound cleansing after exposing to a potentially rabid animal and vaccination using rabies vaccine combined with administration of rabies immune globulin are the only effective methods for post-exposure prophylaxis against rabies. Reverse genetic technique is a novel approach to investigate the function of a specific gene by analyzing the phenotypic effects through directly manipulating the gene sequences. It has revolutionized and provided a powerful tool to study the molecular biology of RNA viruses and has been widely used in rabies virus research. The attenuation of rabies virus virulence is the prerequisite for rabies vaccine development. Given the current challenge that sufficient and affordable high-quality vaccines are limited and lacking for global rabies prevention and control, highly cell-adapted, stable, and attenuated rabies viruses with broad cross-reactivity against different viral variants are ideal candidates for consideration to meet the need for human rabies control in the future. A number of approaches have been pursued to reduce the virulence of the virus and improve the safety of rabies vaccines. The application of reverse genetic technique has greatly advanced the engineering of rabies virus and paves the avenue for utilizing rabies virus for vaccine against rabies, viral vectors for exogenous antigen expression, and gene therapy in the future.
Similar articles
-
Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.Antiviral Res. 2015 Sep;121:9-15. doi: 10.1016/j.antiviral.2015.06.011. Epub 2015 Jun 18. Antiviral Res. 2015. PMID: 26093157
-
Genetic stability (in vivo) of the attenuated oral rabies virus vaccine SAD B19.Microbiol Immunol. 2009 Jan;53(1):16-21. doi: 10.1111/j.1348-0421.2008.00085.x. Microbiol Immunol. 2009. PMID: 19161553
-
From brain passage to cell adaptation: the road of human rabies vaccine development.Expert Rev Vaccines. 2011 Nov;10(11):1597-608. doi: 10.1586/erv.11.140. Expert Rev Vaccines. 2011. PMID: 22043958 Review.
-
Recombinant canine distemper virus serves as bivalent live vaccine against rabies and canine distemper.Vaccine. 2012 Jul 20;30(34):5067-72. doi: 10.1016/j.vaccine.2012.06.001. Epub 2012 Jun 12. Vaccine. 2012. PMID: 22698451
-
The application of reverse genetics technology in the study of rabies virus (RV) pathogenesis and for the development of novel RV vaccines.J Neurovirol. 2005 Feb;11(1):76-81. doi: 10.1080/13550280590900436. J Neurovirol. 2005. PMID: 15804964 Review.
Cited by
-
Rabies Control and Treatment: From Prophylaxis to Strategies with Curative Potential.Viruses. 2016 Oct 28;8(11):279. doi: 10.3390/v8110279. Viruses. 2016. PMID: 27801824 Free PMC article. Review.
-
Research Advances on the Interactions between Rabies Virus Structural Proteins and Host Target Cells: Accrued Knowledge from the Application of Reverse Genetics Systems.Viruses. 2021 Nov 16;13(11):2288. doi: 10.3390/v13112288. Viruses. 2021. PMID: 34835093 Free PMC article. Review.
-
Negative-Strand RNA Virus-Vectored Vaccines.Methods Mol Biol. 2024;2786:51-87. doi: 10.1007/978-1-0716-3770-8_3. Methods Mol Biol. 2024. PMID: 38814390 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources